The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Statement 5.4
“Hospital pharmacists should ensure the reporting of adverse drug reactions and medication errors to regional or national pharmacovigilance programmes or patient safety programmes.”
What does it mean for patients? Adverse drug reactions can occur and must be monitored constantly after marketing approval. The aim of pharmacovigilance reporting programs is to enable authorities to collect the necessary data update the risk-benefit assessments regarding medicines.
What does it mean for healthcare professionals? Reporting of adverse drug reactions is a requirement in order to obtain sufficient data to improve quality and safety of medication practices. Hospital pharmacists can support healthcare professionals to increase reporting and review medication practices.
What does it mean for Hospital Pharmacists? pharmacists should assist health care professionals to increase reporting. Hospital pharmacists should be involved reviewing and monitoring data and define any action needed to improve internal medication practices.
The Fatebenefratelli e Oftalmico Hospital is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
- HOSPITAL PHARMACY UNIFIES ELECTRONIC STANDARD PRESCRIPTION THROUGHOUT THE REGION
- PROTOCOL IMPLEMENTATION FOR PRESCRIBING AND DISPENSING POSTEXPOSURE PROPHYLAXIS KITS FOR HUMAN IMMUNODEFICIENCY VIRUS IN A THIRD-LEVEL HOSPITAL
- IMPLEMENTING THE PRODUCTION OF STERILISED SYRINGES IN THE HOSPITAL: IMPROVING MEDICATION SAFETY AND SAVING HEALTHCARE COSTS
- PROMOTING THE USE OF SAFER INJECTABLE MEDICINES USING A NOVEL METRIC
- EVALUATION OF THE IMPACT OF PATIENT EDUCATION WORKSHOP ON CARDIOVASCULAR PATIENTS USING THE SELF-EFFICACY CONCEPT
- A SET OF QUALITY IMPROVEMENT INTERVENTIONS TO INCREASE THE PERCENTAGE OF STAT IV MEDICINES, MEETING THE GOAL OF BEING READY WITHIN 30 MINUTES
- EAHP Statements Survey 2015-S.5.4" The pharmacist in our hospital report adverse drug reactions?"
- Statement Survey .5.4.5
- EJHP: IDENTIFYING AND REPORTING MEDICATION ERRORS: LEARNING FROM OTHER COUNTRIES
- EAHP Survey Report 2015
- GPI: Influence of integration of a pharmacists in medication errors in critically ill patients
- GPI: HOSPITAL PHARMACY CONTRIBUTION TO CLINICAL TRIALS: TYPIFICATION OF MEDICATION INCIDENTS AND PHARMACEUTICAL INTERVENTIONS IN A CLINICAL TRIAL UNIT
- GPI: IMPLEMENTATION OF A SAFETY ALERT SYSTEM IN A HOSPITAL
- GPI:Improving the quality of ADR reporting
- GPI: INNOVATION AND COLLABORATION New Oral Anticoagulants – Hospital Pharmacists Improving the Safety of Patients
- EAHP Brochure